Literature DB >> 28918196

Expression and purification of human and Saccharomyces cerevisiae equilibrative nucleoside transporters.

Rebba C Boswell-Casteel1, Jennifer M Johnson1, Zygy Roe-Žurž2, Kelli D Duggan1, Hannah Schmitz1, Franklin A Hays3.   

Abstract

Nucleosides play an essential role in the physiology of eukaryotes by acting as metabolic precursors in de novo nucleic acid synthesis and energy metabolism. Nucleosides also act as ligands for purinergic receptors. Equilibrative nucleoside transporters (ENTs) are polytopic integral membrane proteins that aid in regulating plasmalemmal flux of purine and pyrimidine nucleosides and nucleobases. ENTs exhibit broad substrate selectivity across different isoforms and utilize diverse mechanisms to drive substrate flux across membranes. However, the molecular mechanisms and chemical determinants of ENT-mediated substrate recognition, binding, inhibition, and transport are poorly understood. To determine how ENT-mediated transport occurs at the molecular level, greater chemical insight and assays employing purified protein are essential. This article focuses on the expression and purification of human ENT1, human ENT2, and Saccharomyces cerevisiae ScENT1 using novel expression and purification strategies to isolate recombinant ENTs. ScENT1, hENT1, and hENT2 were expressed in W303 Saccharomyces cerevisiae cells and detergent solubilized from the membrane. After detergent extraction, these ENTs were further purified using immobilized metal affinity chromatography and size exclusion chromatography. This effort resulted in obtaining quantities of purified protein sufficient for future biophysical analysis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Membrane proteins; Membrane transport; Membrane transporter reconstitution; Nucleoside nucleotide transport; Transporters

Mesh:

Substances:

Year:  2017        PMID: 28918196      PMCID: PMC5679208          DOI: 10.1016/j.pep.2017.09.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  49 in total

Review 1.  Nucleoside and nucleobase transporters in parasitic protozoa.

Authors:  Scott M Landfear; Buddy Ullman; Nicola S Carter; Marco A Sanchez
Journal:  Eukaryot Cell       Date:  2004-04

2.  Effect of membrane lipid composition on the functional activity of a reconstituted nucleoside transporter derived from Ehrlich ascites cells.

Authors:  J R Hammond
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

3.  Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).

Authors:  M F Vickers; R S Mani; M Sundaram; D L Hogue; J D Young; S A Baldwin; C E Cass
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

4.  Enhancement of the functional stability of solubilized nucleoside transporters by substrates and inhibitors.

Authors:  J R Hammond
Journal:  Biochem Pharmacol       Date:  1997-03-07       Impact factor: 5.858

5.  Species differences in nucleoside transport. A study of uridine transport and nitrobenzylthioinosine binding by mammalian erythrocytes.

Authors:  S M Jarvis; J R Hammond; A R Paterson; A S Clanachan
Journal:  Biochem J       Date:  1982-10-15       Impact factor: 3.857

Review 6.  Ratiocinative screen of eukaryotic integral membrane protein expression and solubilization for structure determination.

Authors:  Franklin A Hays; Zygy Roe-Zurz; Min Li; Libusha Kelly; Franz Gruswitz; Andrej Sali; Robert M Stroud
Journal:  J Struct Funct Genomics       Date:  2008-11-22

Review 7.  The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29.

Authors:  James D Young; Sylvia Y M Yao; Jocelyn M Baldwin; Carol E Cass; Stephen A Baldwin
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 8.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors:  Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

9.  Selecting optimum eukaryotic integral membrane proteins for structure determination by rapid expression and solubilization screening.

Authors:  Min Li; Franklin A Hays; Zygy Roe-Zurz; Linda Vuong; Libusha Kelly; Chi-Min Ho; Renée M Robbins; Ursula Pieper; Joseph D O'Connell; Larry J W Miercke; Kathleen M Giacomini; Andrej Sali; Robert M Stroud
Journal:  J Mol Biol       Date:  2008-11-24       Impact factor: 5.469

Review 10.  Nucleobase and nucleoside transport and integration into plant metabolism.

Authors:  Christopher Girke; Manuel Daumann; Sandra Niopek-Witz; Torsten Möhlmann
Journal:  Front Plant Sci       Date:  2014-09-09       Impact factor: 5.753

View more
  2 in total

1.  Functional Characterization of the Saccharomyces cerevisiae Equilibrative Nucleoside Transporter 1 (ScENT1).

Authors:  Rebba C Boswell-Casteel; Jennifer M Johnson; Franklin A Hays
Journal:  Molecules       Date:  2018-03-22       Impact factor: 4.411

Review 2.  Heterologous (Over) Expression of Human SoLute Carrier (SLC) in Yeast: A Well-Recognized Tool for Human Transporter Function/Structure Studies.

Authors:  Lorena Pochini; Michele Galluccio
Journal:  Life (Basel)       Date:  2022-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.